Medimmune Limited

Sadhana Podichetty

Claire Louise Dobson

David Fairman

Philip Newton

Maria Groves

Matthew Gardener

Jayne Hammersley

Gareth Rees

Richard Williams

Andrew Billinton

Ian Gurrell

Peter Thornton

The present disclosure provides antibodies and antigen-binding fragments capable of binding PrP. The disclosure further provides methods for making and using the antibodies and antigen-binding fragments.

Method for treating a neurodegenerative disease by administering an anti-cellular prion protein (PrP) antibody

The present disclosure provides antibodies and antigen-binding fragments capable of binding PAR2. In some embodiments, the anti-PAR2 antibodies or antigen-binding fragments thereof bind PAR2 in a pH-dependent manner. The disclosure further provides methods for making and using the antibodies and antigen-binding fragments.

Nucleic acids encoding anti-PAR2 antibodies and uses thereof

Anti-PAR2 antibodies and uses thereof

Anti-PrP antibodies and uses thereof

Growing community of inventors

Cambridge, United Kingdom

Sadhana Podichetty